As drug prices rise, the number of complaints against pharmaceutical
companies increase as well. Pressure is being placed on pharmaceutical
companies by leading physicians
to lower the prices on lifesaving drugs.
Doctors From All Around the Country Put the Heat on Pharmaceutical Companies.
At least 118 oncologists from top hospitals
around the country are calling for grassroots solutions to the high costs of cancer treatment. These include Mayo Clinic, University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, and City of Hope Medical Foundation, among others. The doctors
argue that up to 20 percent of cancer patients don’t follow their recommended treatment plan because they can’t afford drugs they need. The oncologists say this financial burden put the sickest Americans at risk as they are fighting for their lives.
have drafted a “prescription” for reducing the high cost of cancer drugs and voiced support for a patient-based grassroots movement demanding action. The doctors
’ commentary summarized in the journal Mayo Clinic Proceedings
on July 23, 2015.
To read Mayo Clinic’s news release, click here
The Situation is Also Being Raised in State Legislatures.
cost transparency bills have been introduced in at least six state legislatures in the last year. They aim to make drug companies justify their high prices, which are often attributed by the companies to high research and development costs.
One bill, which was introduced in the New York State Senate in May 2015, states: “If a prescription drug demands an outrageous price tag, the public, insurers and federal, state and local governments should have access to the information that supposedly justifies the cost.”
It is clear that pharmaceutical
companies charge excessively high prices in the U.S. Citizens of the U.S. routinely travel to Mexico and Canada to obtain the same medications at a fraction of the cost they (or their insurers) would pay here. Even large health
insurers are often able to negotiate greatly reduced prices on medications for which they pay when compared to a cash-paying uninsured patient.
Something must change. State legislatures and Congress should pass legislation to eliminate the “whatever the market will wear” attitude to drug pricing in the U.S.
What do you think of these oncologists’ action plan? Do you think it’ll be successful? Would you join the grassroots movement for this cause? Please leave any thoughtful
Culp-Ressler, Tara. “Drug Prices Soar, Prompting Calls for Justification.” (July 23, 2015). The New York Times
. From: http://nyti.ms/1HKDSPI
About the Author:
George F. Indest III, J.D., M.P.A., LL.M., is Board Certified by The Florida Bar in Health
Law. He is the President and Managing Partner of The Health
Law Firm, which has a national practice. Its main office is in the Orlando, Florida area. www.TheHealthLawFirm.com
Law Firm, 1101 Douglas Ave., Altamonte Springs, FL 32714, Phone: (407) 331-6620.
Mayo Clinic, Big Pharma
, cancer treatment, cancer drugs, drug prices, defense attorney
, oncologists, medical grassroots movement, physician attorney
, pharmacist attorney
care professional, health
care provider, health
care practitioner, prescriber, health
care lawyer, health
law firm, The Health
Law Firm reviews